Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2708 | 257 | 0.4420 | 0.4565 | 0.0949 | 0.0817 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 3526 | 289 | 0.4624 | 0.4885 | 0.0820 | 0.0896 |
A-375 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 3021 | 208 | 0.1530 | 0.1526 | 0.0689 | 0.0765 |
A-375 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 2 | 2993 | 236 | 0.1500 | 0.1526 | 0.0789 | 0.0765 |
A-375 | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 3 | 3098 | 253 | 0.1548 | 0.1526 | 0.0817 | 0.0765 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 2 | 1051 | 926 | 0.0207 | 0.0290 | 0.8811 | 0.8526 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 6456 | 909 | 1.0004 | 1.0000 | 0.1408 | 0.1418 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 1 | 1083 | 877 | 0.0342 | 0.0290 | 0.8098 | 0.8526 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1401 | 69 | 1.0202 | 1.0000 | 0.0493 | 0.0520 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1457 | 1263 | 0.0322 | 0.0290 | 0.8668 | 0.8526 |
COLO 858 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 1 | 6915 | 1096 | 1.0494 | 1.0000 | 0.1585 | 0.1418 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 1049 | 58 | 0.7590 | 0.7202 | 0.0553 | 0.0513 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 1040 | 52 | 0.7567 | 0.7202 | 0.0500 | 0.0513 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 20360 | 1046 | 1.0111 | 1.0000 | 0.0514 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20251 | 1109 | 1.0021 | 1.0000 | 0.0548 | 0.0527 |
A-375 | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 19884 | 1032 | 0.9869 | 1.0000 | 0.0519 | 0.0527 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 2 | 16317 | 808 | 0.9755 | 1.0000 | 0.0495 | 0.0476 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 3 | 16730 | 807 | 1.0016 | 1.0000 | 0.0482 | 0.0476 |
MMAC-SF | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 743 | 233 | 0.3906 | 0.3972 | 0.3136 | 0.3126 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2637 | 462 | 0.3107 | 0.3034 | 0.1752 | 0.1673 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 747 | 248 | 0.3075 | 0.3551 | 0.3320 | 0.3208 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 1046 | 176 | 0.5360 | 0.5003 | 0.1683 | 0.1840 |